Breakthrough medicine Orkambi main factor behind 71% rise in sales

‘As a community we need to use Five Feet Apart as a lever to highlight the situation’

Orkambi will be provided to Irish two to five-year-olds following deal with EU Commission

Success of pharma giants relies on quality of research and ability to develop new drugs

In Dublin, Paddypower still goes up despite UK’s restrictions on betting terminals

Ireland has the highest per capita rate of CF in the world due to particular gene pool

Cystic fibrosis treatment had only been available to people aged 12 and over

News review of the year: Border issues, the Garda whistleblower scandal, property prices, the Paradise Papers, Storm Ophelia and the Rescue 116 tragedy were some of the big stories of 2017

For your Diary: Ryanair, McDonald’s and the banks to reveal trading figures

In Dublin, INM shares take a hammering after company issues profit warning

Up to 600 people with cystic fibrosis will now be able to access life-saving drugs

Decision by Government will be welcomed by the country’s 600 cystic fibrosis patients

Agreement testament to hard work of Cystic Fibrosis Ireland and patients, says Martin

Executive to meet Orkambi maker in bid to secure deal estimated to cost over €250m

Euro slips after Reuters report on wariness of European Central Bank policymakers

Cystic Fibrosis Ireland concerned about lack of contact between HSE and Vertex

Hundreds demonstrate outside Dáil in support of free access to groundbreaking drug

HSE and manufacturer of costly medicine in ‘critical phase’ of discussions on deal

Cystic Fibrosis Ireland warns of ‘strong outcry’ if HSE fails to approve Orkambi on cost

Health body indiciated it would pay up to €75m a year for product estimated to cost €400m